Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,058,034 papers from all fields of science
Search
Sign In
Create Free Account
MF59 oil emulsion
Known as:
MF59
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (4)
Immunologic Adjuvants
Polysorbates
Squalene
Surface-Active Agents
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Safety and Mechanism of Action of Licensed Vaccine Adjuvants
D. S. Rambe
,
G. Giudice
,
S. Rossi
,
Melvin Sanicas
2015
Corpus ID: 42941060
Vaccines are some of the most effective tools for the prevention of infectious diseases. Adjuvants are included in vaccines for a…
Expand
2011
2011
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age
A. Arguedas
,
Carolina Soley
,
+4 authors
R. Clemens
Human Vaccines
2011
Corpus ID: 46194796
Background: The recent global A/H1N1v pandemic led to major efforts to develop effective vaccines against the novel virus, while…
Expand
2010
2010
Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children
Yuji Yasuda
,
R. Komatsu
,
+6 authors
M. Lattanzi
Advances in Therapy
2010
Corpus ID: 3395297
IntroductionThe substantial pandemic (A/H1N1v) influenza disease burden in children highlights the need for effective vaccination…
Expand
2007
2007
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits.
C. Guillon
,
Katia Mayol
,
+6 authors
B. Verrier
Vaccine
2007
Corpus ID: 25155318
Review
2006
Review
2006
Adherence-blocking vaccine for amebiasis.
W. Petri
,
O. Chaudhry
,
R. Haque
,
E. Houpt
Archives of Medical Research
2006
Corpus ID: 15088044
2004
2004
Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
L. Fukasawa
,
W. Dias
,
R. P. Schenkman
,
Isaías Raw
,
M. Tanizaki
FEMS Immunology & Medical Microbiology
2004
Corpus ID: 21875573
2000
2000
Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.
D. O’hagan
,
M. Ugozzoli
,
+5 authors
G. Ott
Vaccine
2000
Corpus ID: 29088784
Highly Cited
1998
Highly Cited
1998
A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.
M. Singh
,
J. Carlson
,
+5 authors
D. O’hagan
Vaccine
1998
Corpus ID: 32746454
Highly Cited
1997
Highly Cited
1997
The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice.
Darci M. Cataldo
,
G. Nest
Vaccine
1997
Corpus ID: 7202275
Highly Cited
1993
Highly Cited
1993
Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant.
W. Keitel
,
R. Couch
,
N. Bond
,
S. Adair
,
G. Van Nest
,
C. Dekker
Vaccine
1993
Corpus ID: 46095885
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE